Company Overview and News

2
MTU / Mitsubishi UFJ Financial Group, Inc. PROSPECTUS SUPPLEMENT (Prospectus)

2018-07-18 sec.gov
Prospectus Supplement Table of Contents CALCULATION OF REGISTRATION FEE
MTU

2
MTU / Mitsubishi UFJ Financial Group, Inc. FREE WRITING PROSPECTUS

2018-07-18 sec.gov
Free Writing Prospectus Issuer Free Writing Prospectus
MTU

2
MOVES- Credit Suisse, MUFG, Vanguard Asset Management

2018-07-17 reuters
July 17 (Reuters) - The following financial services industry appointments were announced on Tuesday. To inform us of other job changes, email [email protected]
8306 MUFG MBFJF MTU

2
MTU / Mitsubishi UFJ Financial Group, Inc. PRELIMINARY PROSPECTUS SUPPLEMENT (Prospectus)

2018-07-17 sec.gov
Preliminary Prospectus Supplement Table of Contents The information in this preliminary prospectus supplement is incomplete and may be changed. This preliminary prospectus supplement and the accompanying prospectus are not an offer to sell these securities and are not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.
MTU

2
MOVES-MUFG Investor Services adds executives in London office

2018-07-17 reuters
(Reuters) - MUFG Investor Services, the asset servicing arm of Mitsubishi UFJ Financial Group Inc (8306.T), said it had appointed Oliver Scully as head of EMEA sales and David Sarfas as global head of private equity.
8306 MUFG MBFJF MTU

2
UPL seeks $3 billion loan to buy Bill Ackman-backed Arysta

2018-07-17 livemint
Mumbai: Indian chemical producer UPL Ltd is seeking a loan of about $3 billion to help fund its bid for a Platform Specialty Products Corp. agricultural pesticides unit backed by shareholder activist Bill Ackman, people familiar with the matter said.
PAH 8306 MUFG MBFJF MTU

2
UPL seeks US$3 bil loan to buy Ackman-backed Arysta

2018-07-17 theedgemarkets
(July 17): Indian chemical producer UPL Ltd is seeking a loan of about US$3 billion to help fund its bid for a Platform Specialty Products Corp agricultural pesticides unit, backed by shareholder activist Bill Ackman, people with knowledge of the matter said.
PAH 8306 MUFG MBFJF MTU

3
Japan’s banks turn to new ATM strategies

2018-07-15 thestar.com.my
A WHITE truck was parked outside a supermarket in Mishima, Shizuoka Prefecture, in late June, with a notable message on its side: "Equipped with a counter and ATM".
MZHOF SKLKY 9020 SMFG SMFNF SEBNF SVNBY KDDIY 8306 4689 9437 8303 YAHOY KDDIF RKUNY MBFJF DCM 8361 JOYOF SZKBF RKUNF SHZUY YAHOF 8316 SKLKF MUFG NTDMF 8411 8355 8410 MTU MFG LN

2
MTU / Mitsubishi UFJ Financial Group, Inc. FORM 6-K (Current Report of Foreign Issuer)

2018-07-13 sec.gov
Form 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
MTU

2
MTU / Mitsubishi UFJ Financial Group, Inc. FORM 6-K (Current Report of Foreign Issuer)

2018-07-13 sec.gov
Form 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
MTU

2
MTU / Mitsubishi UFJ Financial Group, Inc. FORM 6-K (Current Report of Foreign Issuer)

2018-07-13 sec.gov
Form 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
MTU

2
Japan to suspend MUFG unit's primary dealer status for a month - sources

2018-07-13 reuters
TOKYO, July 13 (Reuters) - Japan’s finance ministry plans to suspend the primary dealer status given to Mitsubishi UFJ Morgan Stanley Securities for one month effective July 18, according to sources close to the matter.
8306 MUFG MBFJF MTU

2
Japanese banks MUFG, Mizuho to stop Iranian transactions

2018-07-12 theedgemarkets
TOKYO (July 12): Japanese banks are moving to stop handling all Iran-related transactions to meet a November deadline set by the United States, after President Donald Trump in May pulled out of a nuclear programme agreement with Tehran.
MZHOF 8306 MUFG 8411 MBFJF MTU MFG

2
MTU / Mitsubishi UFJ Financial Group, Inc. ANNUAL REPORT

2018-07-12 sec.gov
ANNUAL REPORT Table of Contents As filed with the Securities and Exchange Commission on July 12, 2018 UNITED STATES
MTU

2
MTU / Mitsubishi UFJ Financial Group, Inc. IRAN NOTICE

2018-07-12 sec.gov
IRAN NOTICE Mitsubishi UFJ Financial Group, Inc. 7-1, Marunouchi 2-chome Chiyoda-ku, Tokyo 100-8330 Japan
MTU

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to MTU / Mitsubishi UFJ Financial Group, Inc. on message board site Silicon Investor.

CEMJQ - Chemtura Corp. Phoenix Metals U.S.A. - PMTU
Mantaur Petroleum MTUR Phoenix Metals USA (PMTU) platinum group/gold/silver
CUSIP: 606822104